Lv55
1236 积分 2025-05-21 加入
Evaluation of the safety, biodistribution, dosimetry of [18F]AlF-NYM005 and initial experience in clear cell renal cell carcinoma: an interim analysis of a prospective trial
7天前
已完结
[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial
7天前
已完结
A prospective head-to-head comparison of 18F-NYM005 PET/CT and 18F-FDG PET/CT in diagnosing renal cell carcinoma
1个月前
已完结
Radiation Therapy for Renal Cell Carcinoma
1个月前
已完结
A Phase 2, Open-Label, Randomized Controlled Trial Evaluating Safety and Efficacy of Dose-Intensified Versus Standard Dosing Regimens of [177Lu]Lu-PSMA-597 in mCRPC (OPTIMAL-PSMA)
1个月前
已完结
A Phase 2, Open-Label, Randomized Controlled Trial Evaluating Safety and Efficacy of Dose-Intensified Versus Standard Dosing Regimens of [177Lu]Lu-PSMA-597 in mCRPC (OPTIMAL-PSMA)
1个月前
已完结
The molecular blueprint of targeted radionuclide therapy
2个月前
已完结
Gastroenteropancreatic Neuroendocrine Tumors
2个月前
已完结
Exploiting the folate receptor α in oncology
3个月前
已完结
Ovarian cancer
3个月前
已完结
皖公网安备34019202002308
